Tauber J - Search Results

1

Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).

Holland EJ, Luchs J, Karpecki PM, Nichols KK, Jackson MA, Sall K, Tauber J, Roy M, Raychaudhuri A, Shojaei A. Holland EJ, et al. Among authors: tauber j. Ophthalmology. 2017 Jan;124(1):53-60. doi: 10.1016/j.ophtha.2016.09.025. Epub 2016 Oct 27. Ophthalmology. 2017. PMID: 28079022 Free article. Clinical Trial.

2

Excimer photorefractive keratectomy for myopia.

Piebenga LW, Matta CS, Deitz MR, Tauber J, Irvine JW, Sabates FN. Piebenga LW, et al. Among authors: tauber j. Ophthalmology. 1993 Sep;100(9):1335-45. doi: 10.1016/s0161-6420(13)31819-3. Ophthalmology. 1993. PMID: 8371921

3

Excimer retreatment for myopic photorefractive keratectomy failures. Six- to 18-month follow-up.

Matta CS, Piebenga LW, Deitz MR, Tauber J. Matta CS, et al. Among authors: tauber j. Ophthalmology. 1996 Mar;103(3):444-51. doi: 10.1016/s0161-6420(96)30673-8. Ophthalmology. 1996. PMID: 8600421

4

Two-zone excimer photorefractive keratectomy for moderate myopia. Six- to 18-month follow-up.

Piebenga LW, Matta CS, Deitz MR, Tauber J. Piebenga LW, et al. Among authors: tauber j. Ophthalmology. 1995 Jul;102(7):1054-9. doi: 10.1016/s0161-6420(95)30912-8. Ophthalmology. 1995. PMID: 9121752

5

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.

Stevenson D, Tauber J, Reis BL. Stevenson D, et al. Among authors: tauber j. Ophthalmology. 2000 May;107(5):967-74. doi: 10.1016/s0161-6420(00)00035-x. Ophthalmology. 2000. PMID: 10811092 Clinical Trial.

6

Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.

Tauber J, Davitt WF, Bokosky JE, Nichols KK, Yerxa BR, Schaberg AE, LaVange LM, Mills-Wilson MC, Kellerman DJ. Tauber J, et al. Cornea. 2004 Nov;23(8):784-92. doi: 10.1097/01.ico.0000133993.14768.a9. Cornea. 2004. PMID: 15502479 Clinical Trial.

7

Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.

Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Barber LD, et al. Among authors: tauber j. Ophthalmology. 2005 Oct;112(10):1790-4. doi: 10.1016/j.ophtha.2005.05.013. Ophthalmology. 2005. PMID: 16102833 Clinical Trial.

8

Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome.

Tauber J. Tauber J. Curr Med Res Opin. 2007 Nov;23(11):2629-36. doi: 10.1185/030079907x233197. Curr Med Res Opin. 2007. PMID: 17868503 Clinical Trial.

9

The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, Rolando M, Tsubota K, Nichols KK. Geerling G, et al. Among authors: tauber j. Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):2050-64. doi: 10.1167/iovs.10-6997g. Invest Ophthalmol Vis Sci. 2011. PMID: 21450919 Free PMC article. Review. No abstract available.

10

Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases.

Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza MT, Foster CS. Gonzalez-Gonzalez LA, et al. Among authors: tauber j. Ophthalmology. 2012 Jul;119(7):1460-4. doi: 10.1016/j.ophtha.2012.01.033. Epub 2012 Mar 28. Ophthalmology. 2012. PMID: 22463821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters